<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) which has a risk of leukaemic change exhibit a variable clinical course </plain></SENT>
<SENT sid="1" pm="."><plain>It has been suggested that the development of <z:mpath ids='MPATH_336'>leukaemia</z:mpath> in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> may be related to chromosomal abnormalities or genetic alterations: <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> of the N-ras gene is now considered to be a critical step in the genetic basis of human leukaemogenesis </plain></SENT>
<SENT sid="2" pm="."><plain>Here we report that DNAs of bone-marrow cells from three out of eight patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> contained an activated N-ras oncogene, as detected by an in vivo selection assay in <z:mp ids='MP_0003815'>nude</z:mp> mice with transfected NIH 3T3 cells </plain></SENT>
<SENT sid="3" pm="."><plain>Molecular analysis revealed the same single nucleotide substitution at codon 13 in <z:hpo ids='HP_0000001'>all</z:hpo> three transforming N-ras genes </plain></SENT>
<SENT sid="4" pm="."><plain>Each of the three patients showed a progression of the disease and a resulting leukaemic change within the following year </plain></SENT>
<SENT sid="5" pm="."><plain>Our observation of the mutation at codon 13 in leukaemic cell DNAs from <z:hpo ids='HP_0000001'>all</z:hpo> three cases suggests that activation of the N-ras gene is important in the development of <z:mpath ids='MPATH_336'>leukaemia</z:mpath> in some <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cases </plain></SENT>
</text></document>